Identification of SHMT2 as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Lung Adenocarcinoma

Figure 8

Kaplan-Meier survival analysis. (a) OS (overall survival) of SHMT2 in GSE21933. (b) OS (overall survival) of SHMT2 in GSE31210. The numbers below the figures represent the number of patients at risk in each group. (c and d) Kaplan-Meier survival curves comparing the high and low expression of SHMT2 in LUAD in the Kaplan-Meier plotter database and GEPIA database.

(a)

(b)

(c)

(d)